Literature DB >> 10899071

Preservation of glucose metabolism in hypertrophic GLUT4-null hearts.

A E Stenbit1, E B Katz, J C Chatham, D L Geenen, S M Factor, R G Weiss, T S Tsao, A Malhotra, V P Chacko, C Ocampo, L A Jelicks, M J Charron.   

Abstract

GLUT4-null mice lacking the insulin-sensitive glucose transporter are not diabetic but do exhibit abnormalities in glucose and lipid metabolism. The most striking morphological consequence of ablating GLUT4 is cardiac hypertrophy. GLUT4-null hearts display characteristics of hypertrophy caused by hypertension. However, GLUT4-null mice have normal blood pressure and maintain a normal cardiac contractile protein profile. Unexpectedly, although they lack the predominant glucose transporter in the heart, GLUT4-null hearts transport glucose and synthesize glycogen at normal levels, but gene expression of rate-limiting enzymes involved in fatty acid oxidation is decreased. The GLUT4-null heart represents a unique model of hypertrophy that may be used to study the consequences of altered substrate utilization in normal and pathophysiological conditions.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10899071     DOI: 10.1152/ajpheart.2000.279.1.H313

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  11 in total

Review 1.  Energetics and metabolism in the failing heart: important but poorly understood.

Authors:  Aslan T Turer; Craig R Malloy; Christopher B Newgard; Mihai V Podgoreanu
Journal:  Curr Opin Clin Nutr Metab Care       Date:  2010-07       Impact factor: 4.294

Review 2.  Metabolic therapy at the crossroad: how to optimize myocardial substrate utilization?

Authors:  Stephen C Kolwicz; Rong Tian
Journal:  Trends Cardiovasc Med       Date:  2009-08       Impact factor: 6.677

3.  Development of GLUT4-selective antagonists for multiple myeloma therapy.

Authors:  Changyong Wei; Richa Bajpai; Horrick Sharma; Monique Heitmeier; Atul D Jain; Shannon M Matulis; Ajay K Nooka; Rama K Mishra; Paul W Hruz; Gary E Schiltz; Mala Shanmugam
Journal:  Eur J Med Chem       Date:  2017-08-14       Impact factor: 6.514

Review 4.  Magnetic resonance imaging and spectroscopy of the murine cardiovascular system.

Authors:  Ashwin Akki; Ashish Gupta; Robert G Weiss
Journal:  Am J Physiol Heart Circ Physiol       Date:  2013-01-04       Impact factor: 4.733

Review 5.  Insulin signaling in heart muscle: lessons from genetically engineered mouse models.

Authors:  E Dale Abel
Journal:  Curr Hypertens Rep       Date:  2004-12       Impact factor: 5.369

6.  Glucose kinetics and exercise tolerance in mice lacking the GLUT4 glucose transporter.

Authors:  Patrick T Fueger; Candice Y Li; Julio E Ayala; Jane Shearer; Deanna P Bracy; Maureen J Charron; Jeffrey N Rottman; David H Wasserman
Journal:  J Physiol       Date:  2007-05-10       Impact factor: 5.182

7.  Myocardial oxidative stress, osteogenic phenotype, and energy metabolism are differentially involved in the initiation and early progression of delta-sarcoglycan-null cardiomyopathy.

Authors:  Comlan Missihoun; David Zisa; Arsalan Shabbir; Huey Lin; Techung Lee
Journal:  Mol Cell Biochem       Date:  2008-08-26       Impact factor: 3.396

8.  GLUT4, GLUT1, and GLUT8 are the dominant GLUT transcripts expressed in the murine left ventricle.

Authors:  Lauren Aerni-Flessner; Melissa Abi-Jaoude; Amanda Koenig; Maria Payne; Paul W Hruz
Journal:  Cardiovasc Diabetol       Date:  2012-06-08       Impact factor: 9.951

9.  Sitagliptin improved glucose assimilation in detriment of fatty-acid utilization in experimental type-II diabetes: role of GLP-1 isoforms in Glut4 receptor trafficking.

Authors:  E Ramírez; B Picatoste; A González-Bris; M Oteo; F Cruz; A Caro-Vadillo; J Egido; J Tuñón; M A Morcillo; Ó Lorenzo
Journal:  Cardiovasc Diabetol       Date:  2018-01-11       Impact factor: 9.951

Review 10.  Linking metabolic dysfunction with cardiovascular diseases: Brn-3b/POU4F2 transcription factor in cardiometabolic tissues in health and disease.

Authors:  Vishwanie S Budhram-Mahadeo; Matthew R Solomons; Eeshan A O Mahadeo-Heads
Journal:  Cell Death Dis       Date:  2021-03-12       Impact factor: 8.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.